Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

amgen switzerland ag - darbepoetinum alfa - injektionslösung in vorgefülltem pen (sureclick) - darbepoetinum alfa 130 µg, natrii phosphates, natrii chloridum, polysorbatum 80, aqua ad iniectabilia q.s. ad solutionem pro 0.65 ml corresp., darbepoetinum alfa 200 µg/ml. - stimulierung der erythropoese - biotechnologika

Europäische Union - Deutsch - EMA (European Medicines Agency)

roche registration gmbh - methoxy-polyethylenglycol-epoetin beta - anemia; kidney failure, chronic - antianämische präparate - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa adnr - injektionslösung - epoetinum alfa adnr 2000 u.i., natrii chloridum, natrii phosphates, glycinum, polysorbatum 80, aqua ad iniectabilia q.s. ad solutionem pro 1 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa adnr - injektionslösung - epoetinum alfa adnr 4000 u.i., natrii chloridum, natrii phosphates, glycinum, polysorbatum 80, aqua ad iniectabilia q.s. ad solutionem pro 1 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa adnr - injektionslösung - epoetinum alfa adnr 10000 u.i., natrii chloridum, natrii phosphates, glycinum, polysorbatum 80, aqua ad iniectabilia q.s. ad solutionem pro 1 ml. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa - injektionslösung (fertigspritzen) - epoetinum alfa 1000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.298 mg. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa - injektionslösung (fertigspritzen) - epoetinum alfa 2000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.359 mg. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa - injektionslösung (fertigspritzen) - epoetinum alfa 3000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp. natrium 0.926 mg. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa - injektionslösung (fertigspritzen) - epoetinum alfa 4000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 1.235 mg. - stimulierung der erythropoese - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - epoetinum alfa - injektionslösung (fertigspritzen) - epoetinum alfa 10000 u.i., polysorbatum 80, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, glycinum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 3.087 mg. - stimulierung der erythropoese - biotechnologika